HALKUFF DAWN received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/5/2024ACC: 0001867096-24-000103
Director
Since Oct 2021
+50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
87.0%
6/5/2024
57.50K→107.50K
Total
Net shares
+50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2024 | A · Award | +50K | — | — | 87.0% | 57.50K | 107.50K |
| Total | +50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned5.41K
Total
5.41K indirect5.41K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.41K | Indirect |
| Total | 5.41K | 5.41K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported